HIGHLIGHTS   |  January 30, 2020   Treatment Combination May Be Effective for Antitumor Activity in Advanced Sarcoma The combination of talimogene laherparepvec and pembrolizumab was associated with antitumor activity across a range of sarcoma histologic subtypes in this phase II clinical trial. Read more   FDA Approves Tazemetostat for the Treatment of Epithelioid Sarcoma The FDA granted accelerated approval of tazemetostat (Tazverik) based on data reported in a phase II clinical trial of the methyltransferase inhibitor. Read more   ICYMI: Engaging in the Recommended Amount of Physical Activity May Help Prevent 7 Cancer Types Though physical activity guidelines are largely based on chronic diseases like cardiovascular disease and diabetes, these data suggest they are important to cancer prevention as well. Read more